Locations:
Search
Highlights from one of the most active therapeutic clinical trials programs in the U.S.
Number of brain metastases doesn’t matter for ALK/EGFR+ patients
28-patient series suggests other dosages, delivery approaches should be studied
Results from calcification volume quantification of intracranial and extracranial arteries
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Database studies find risks related to race, insurance type, geography
Study shows MRI infarct growth surges thereafter
Copy number variants may help predict clinical outcomes
Patterns of brain atrophy differ between active and retired boxers
Knocking out, then restoring, the immune system holds great promise
Capecitabine-based approach shows promise in a population with few options
Advertisement
Advertisement